Want to join the conversation?
$CELG announced interim topline data from trial of investigational oral GED-0301 in patients with active Crohn's disease. Crohn's disease is an immune-mediated, chronic inflammatory condition of the gastrointestinal tract. The primary objective of the study is to explore the effect of GED-0301 on endoscopic outcomes.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?